I would have thought baby poison would be selling at a slight discount to regular or premium baby formula. Maybe that's just my wrong perception of the Chinese customer:
https://www.reuters.com/article/us-...amino-infant-formula-in-germany-idUSKBN1O50I2
Also note, that for Citi to recommend a BUY on Nestle, a $257B entity, because they might have a small increase in one component of their overall business, shows me the value of the report and intentions of the report.
I hope you are buying up big on Nestle! GL.
Citi Research - Nestle to Win, page-4
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.77 |
Change
0.130(1.96%) |
Mkt cap ! $4.894B | |||
| Open | High | Low | Value | Volume |
| $6.63 | $6.77 | $6.63 | $10.00M | 1.485M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2420 | $6.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.77 | 37726 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |